TipRanks
Yield10 Bioscience (YTENQ)
OTHER OTC:YTENQ
US Market
Want to see YTENQ full AI Analyst Report?

Yield10 Bioscience (YTENQ) Stock Statistics & Valuation Metrics

330 Followers

Total Valuation

Yield10 Bioscience has a market cap or net worth of $1.00. The enterprise value is $2.80M.
Market Cap$1.00
Enterprise Value$2.80M

Share Statistics

Yield10 Bioscience has 692,683 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding692,683
Owned by Insiders―
Owned by Institutions―

Financial Efficiency

Yield10 Bioscience’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count29
Asset Turnover―
Inventory Turnover―

Valuation Ratios

The current PE Ratio of Yield10 Bioscience is ―. Yield10 Bioscience’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―

Income Statement

In the last 12 months, Yield10 Bioscience had revenue of ― and earned -14.46M in profits. Earnings per share was ―.
Revenue―
Gross Profit60.00K
Operating Income-14.42M
Pretax Income―
Net Income-14.46M
EBITDA-14.16M
Earnings Per Share (EPS)―

Cash Flow

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―

Dividends & Yields

Yield10 Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―

Stock Price Statistics

Beta85.87
52-Week Price Change―
50-Day Moving Average0.02
200-Day Moving Average0.39
Relative Strength Index (RSI)28.42
Average Volume (3m)0.00

Important Dates

Yield10 Bioscience upcoming earnings date is Aug 18, 2025, After Close (Confirmed).
Last Earnings DateMay 7, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―

Financial Position

Yield10 Bioscience as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―

Taxes

In the past 12 months, Yield10 Bioscience has paid ― in taxes.
Income Tax―
Effective Tax Rate―

Enterprise Valuation

Yield10 Bioscience EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―

Balance Sheet

Yield10 Bioscience has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―

Analyst Forecast

The average price target for Yield10 Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―

Scores

Smart ScoreN/A
AI Score―